Back to Search
Start Over
Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage
- Source :
- Antimicrobial agents and chemotherapy, vol 60, iss 1
- Publication Year :
- 2015
- Publisher :
- American Society for Microbiology, 2015.
-
Abstract
- HIV-1 infection frequently causes HIV-associated neurocognitive disorders (HAND) despite combination antiretroviral therapy (cART). Evidence is accumulating that components of cART can themselves be neurotoxic upon long-term exposure. In addition, abuse of psychostimulants, such as methamphetamine, seems to aggravate HAND and compromise antiretroviral therapy. However, the combined effect of virus and recreational and therapeutic drugs on the brain is poorly understood. Therefore, we exposed mixed neuronal-glial cerebrocortical cells to antiretrovirals (ARVs) (zidovudine [AZT], nevirapine [NVP], saquinavir [SQV], and 118-D-24) of four different pharmacological categories and to methamphetamine and, in some experiments, the HIV-1 gp120 protein for 24 h and 7 days. Subsequently, we assessed neuronal injury by fluorescence microscopy, using specific markers for neuronal dendrites and presynaptic terminals. We also analyzed the disturbance of neuronal ATP levels and assessed the involvement of autophagy by using immunofluorescence and Western blotting. ARVs caused alterations of neurites and presynaptic terminals primarily during the 7-day incubation and depending on the specific compounds and their combinations with and without methamphetamine. Similarly, the loss of neuronal ATP was context specific for each of the drugs or combinations thereof, with and without methamphetamine or viral gp120. Loss of ATP was associated with activation of AMP-activated protein kinase (AMPK) and autophagy, which, however, failed to restore normal levels of neuronal ATP. In contrast, boosting autophagy with rapamycin prevented the long-term drop of ATP during exposure to cART in combination with methamphetamine or gp120. Our findings indicate that the overall positive effect of cART on HIV infection is accompanied by detectable neurotoxicity, which in turn may be aggravated by methamphetamine.
- Subjects :
- 0301 basic medicine
Cell Culture Techniques
Pharmacology
AMP-Activated Protein Kinases
HIV Envelope Protein gp120
Methamphetamine
Rats, Sprague-Dawley
Substance Misuse
0302 clinical medicine
Adenosine Triphosphate
Homeostasis
Pharmacology (medical)
Saquinavir
Cerebral Cortex
Neurons
virus diseases
Pharmacology and Pharmaceutical Sciences
Recombinant Proteins
Drug Combinations
Infectious Diseases
medicine.anatomical_structure
Embryo
Medical Microbiology
HIV/AIDS
Neuroglia
Infection
Zidovudine
medicine.drug
Cart
Nevirapine
Presynaptic Terminals
Biology
Microbiology
Antiviral Agents
03 medical and health sciences
medicine
Autophagy
Animals
HIV Integrase Inhibitors
Protein kinase A
Sirolimus
Mammalian
Neurosciences
Neurotoxicity
medicine.disease
Embryo, Mammalian
Brain Disorders
Rats
Good Health and Well Being
030104 developmental biology
Sprague-Dawley
Drug Abuse (NIDA only)
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Antimicrobial agents and chemotherapy, vol 60, iss 1
- Accession number :
- edsair.doi.dedup.....efa69109580e8a65c1b10f56a98dbefb